Search Results

Site Search

Chromosomal microarray - Insights

Learn how our microarray evaluations identify, analyze, and assess clinically significant chromosomal abnormalities.

Own your lab, own your future - Insights

The laboratory is the cornerstone for health systems that offer complex care. Learn how lab ownership is a key driver of patient care excellence and health system growth.

Mayo Clinic Laboratory and Pathology Research Roundup: March 13 - Insights

This week’s Research Roundup highlights the clinical and pathological evolution of giant cell arteritis with a prospective study of follow-up temporal artery biopsies in 40 treated patients.

November 2023 - Gynecological Pathology / Laboratory Genetics and Genomics - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Gynecological Pathology and Laboratory Genetics and Genomics.

CPT codes and LOINC update: May 2024 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of May.

Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 20 - Insights

This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.

COVID-19 weekly news: March 7-11 2022 - Insights

Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.

Dr. Dong Chen and Dr. Sounak Gupta join Becker's Healthcare Podcast to discuss molecular testing in cancer care - Insights

Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the...

Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights

This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...

August 2023 - Hematopathology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Hematopathology.

Week in Review: April 29 - Insights

Today's highlights include: CDC estimates 3 in 4 kids have had coronavirus infections, virtual in-person cardiac rehabilitation provide similar benefits, and Mayo Clinic partners with AI startup to co-develop precision medicine.

Week in Review: May 6 - Insights

Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision

FDA Regulation of Laboratory Developed Tests - Insights

PACE/State of FL - A brief history of the FDA’s interest in LDTs and detailing new requirements.

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...

New tests launched in July - Insights

In July 2022, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D. - Insights

Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these...

MAG Antibody Testing [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...

Hereditary peripheral neuropathy - Insights

Learn how our test menu can assist in identifying genetic causes across the spectrum of hereditary peripheral neuropathies.

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D. - Insights

Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy...

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D. - Insights

Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's...

When is it Cool to Drool? Oral Fluid Testing for Controlled Substance Monitoring - Insights

PACE/State of FL - Substance use disorders and the common laboratory tests and matrices used for controlled substance monitoring.

Testing Aids Nicotine-Use Cessation: Paul Jannetto, Ph.D. - Insights

Tobacco use is the leading cause of preventable death in the United States. In this test-specific episode of the "Answers From the Lab" podcast, Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients...

Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights

Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D. - Insights

Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.

Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights

Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D. - Insights

Maria Willrich, Ph.D., and Melissa Snyder, Ph.D., describe Mayo Clinic Laboratories' panel for proactive therapeutic drug monitoring of patients with inflammatory bowel disease. The panel expands options for clinicians assessing patients'...

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D. - Insights

John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test can detect antihypertensive medications in urine, providing evidence of...

Doing More with Less: The Advantages of Optimizing Blood Collection Volumes for Laboratory Testing - Insights

P.A.C.E./Florida - Implementation of new analyzers and replacement of automation equipment in the Central Clinical Laboratory at Mayo Clinic in Rochester, Minnesota, prompted the laboratory to reassess blood collection volumes for commonly...

Integration, innovation, precision: Propelling leading-edge diagnostics - Insights

The third episode of “Life of a Specimen” video series discusses the integration that drives the development of innovative tests, including the movement disorders evaluation, at Mayo Clinic Laboratories.

Use of Artificial Intelligence and Digital Slide Scanning for Detection of Intestinal Protozoa in Trichrome-Stained Stool Specimens - Insights

In this month's "Hot Topic," Bobbi Pritt, M.D., describes the challenges to traditional microscopy for the detection of protozoa in stool specimens, lists potential uses of artificial intelligence in parasite detection, and discusses...

Newborn Screening at Mayo Clinic Laboratories

Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.

Operational updates - Insights

The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.

Neuromuscular disorders - Insights

Learn more about our specialized testing for neuromuscular diseases, including myasthenia gravis, Lambert-Eaton syndrome, and more.

Newsroom - Insights

The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at newsbureau@mayo.edu, attention: Mayo Clinic Laboratories.

Allergens - Insights

Browse our menu of immunoglobulin E (IgE) antibody testing, which can be useful in the evaluation of patients suspected of having an allergic disease.

Specialty testing - Insights

Commercial laboratories partners have access to Mayo Clinic Laboratories full menu of subspecialty testing, which spans the spectrum of medical specialties.

Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights

Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally.

New Year's Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered for the New Year's holiday. To ensure specimen viability and minimize delays, the following adjustments and guidelines have been implemented and will be...

Christmas Specimen Shipping Guidelines and Schedule - Insights

Due to the Christmas holiday (recognized on Wednesday, Dec. 25), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for...

Phlebotomy - Insights

The Phlebotomy Resource Page is a compilation of on demand content, presentations, and other phlebotomy-related education.

Therapeutic Drug Monitoring for Biologics in Inflammatory Bowel Disease - Insights

PACE/State of FL - Laboratory tests available at Mayo Clinic Laboratories to monitor patients using monoclonal antibody therapies for treatment of inflammatory bowel disease.

Research Suggests Genetics Are Key in Treating Night Sweats - Insights

Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some women needing more estrogen than others to get relief. A new Mayo Clinic study published in Menopause: The Journal of the...

Diagnosis and inflammation monitoring - Insights

Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.

Mayo Clinic Laboratory and Pathology Research Roundup: May 7 - Insights

This week’s Research Roundup highlights how fasting blood-glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis.

Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights

This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.

New Years Holiday Shipment Schedules - Insights

The United States will observe the New Year holiday on Monday, Jan. 1. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard...

Mayo Clinic Laboratory and Pathology Research Roundup: December 26 - Insights

This week's research roundup feature: Histoplasma and Blastomyces antigen detection assays are commonly used diagnostic tools. However, a high level of cross-reactivity between these antigens prevents definitive pathogen identification by...

Confirmatory testing - Insights

Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.

Tick-borne coinfection - Insights

Browse our suite of serological and molecular testing designed to detect tick-borne pathogen coinfections.

Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 10 - Insights

This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.